General Information of the Molecule (ID: Mol01089)
Name
Sterol 14-alpha demethylase cyp51A (CYP51A) ,Aspergillus terreus
Synonyms
ATEIFO6365_0007029700; ATETN484_0009029700
    Click to Show/Hide
Molecule Type
Protein
Gene Name
ATEIFO6365_0007029700
Sequence
MIMSLLTITSYSAVGILALIAWNVIRQLLFQNKSEPPVVFHWIPFLGSTISYGIDPYAFF
ASCRQKYGDIFTFILLGQKTTVYLGVQGNEFILNGKLKDVNAEEVYSPLTTPVFGSDVVY
DCPNAKLMEQKKFIKYGLTQAALESHVQLIEREVLDYLRTSPNFHGASGVVDISAAMAEL
TIFTAGRALQGEEVRRKLTAEFADLYHDLDKGFTPINFMLPWAPLPHNRKRDAAHARMRA
IYMDIIRERRAHKNPDQGEAGSDSDMIWNLMRCTYKDGRPVPDKEIAHMMITLLMAGQHS
SSSISAWIFLRLASEPRVLEELYQEQVASLGKPDADGAFPPLQFRDLDRLPLHQNVVKET
LRLHSSIHSIMRKVKNPLPVPGTPYVVPTSHVLLASPGVTATSDEYFPNASRWDPHRWEN
HAEPDDDDGEMVDYGYGRVSKGTASPYLPFGGGRHRCIGEKFAYINLGVIVATVVRHLKL
FNVDGRKGVPPTDYSSLFSGPLKPAIIGWERRFPTA
    Click to Show/Hide
Uniprot ID
A0A5M3Z4K7_ASPTE
        Click to Show/Hide the Complete Species Lineage
Kingdom: Fungi
Phylum: Ascomycota
Class: Eurotiomycetes
Order: Eurotiales
Family: Aspergillaceae
Genus: Aspergillus
Species: Aspergillus terreus
Type(s) of Resistant Mechanism of This Molecule
  ADTT: Aberration of the Drug's Therapeutic Target
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Click to Show/Hide the Full List of Drugs
Itraconazole
Click to Show/Hide
Drug Resistance Data Categorized by Their Corresponding Mechanisms
       Aberration of the Drug's Therapeutic Target (ADTT) Click to Show/Hide
Disease Class: Chronic noninvasive aspergillosis [1]
Resistant Disease Chronic noninvasive aspergillosis [ICD-11: 1F20.4]
Resistant Drug Itraconazole
Molecule Alteration Missense mutation
p.M217I
Experimental Note Identified from the Human Clinical Data
In Vitro Model Aspergillus terreus strain 33178
Experiment for
Molecule Alteration
DNA sequencing assay
Experiment for
Drug Resistance
Broth microdilution method assay
Mechanism Description In vivo emergence of Aspergillus terreus with reduced azole susceptibility which is related to Cyp51a M217I alteration.
References
Ref 1 In vivo emergence of Aspergillus terreus with reduced azole susceptibility and a Cyp51a M217I alteration. J Infect Dis. 2012 Sep 15;206(6):981-5. doi: 10.1093/infdis/jis442. Epub 2012 Jul 10.

If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.